Cargando…
Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japan Atherosclerosis Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803835/ https://www.ncbi.nlm.nih.gov/pubmed/32507831 http://dx.doi.org/10.5551/jat.ED130 |
| _version_ | 1783636030832771072 |
|---|---|
| author | Nomiyama, Takashi |
| author_facet | Nomiyama, Takashi |
| author_sort | Nomiyama, Takashi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7803835 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Japan Atherosclerosis Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78038352021-01-27 Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? Nomiyama, Takashi J Atheroscler Thromb Editorial Japan Atherosclerosis Society 2020-11-01 /pmc/articles/PMC7803835/ /pubmed/32507831 http://dx.doi.org/10.5551/jat.ED130 Text en 2020 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Editorial Nomiyama, Takashi Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title | Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title_full | Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title_fullStr | Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title_full_unstemmed | Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title_short | Can SGLT2 Inhibitor be Used for Diabetes Mellitus or Vascular Diseases? |
| title_sort | can sglt2 inhibitor be used for diabetes mellitus or vascular diseases? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803835/ https://www.ncbi.nlm.nih.gov/pubmed/32507831 http://dx.doi.org/10.5551/jat.ED130 |
| work_keys_str_mv | AT nomiyamatakashi cansglt2inhibitorbeusedfordiabetesmellitusorvasculardiseases |